Related Experiment Video
Updated: Aug 16, 2025

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Nicotine replacement therapy for vaping cessation among mono and dual users: A mixed methods preliminary study
Amanda M Palmer1, Matthew J Carpenter2, Alana M Rojewski3
1Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA; Department of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA.
Adults seeking to quit e-cigarettes are motivated by health and cost concerns. Nicotine replacement therapy (NRT) shows promise as a feasible and acceptable cessation aid, with some participants achieving abstinence.
Area of Science:
- Public Health
- Addiction Medicine
- Behavioral Science
Background:
- Limited empirically tested interventions exist for adult e-cigarette cessation.
- Adults express significant interest in quitting vaping due to various concerns.
Purpose of the Study:
- To evaluate adult e-cigarette users' reasons for cessation.
- To assess the feasibility and acceptability of nicotine replacement therapy (NRT) for vaping cessation.
Main Methods:
- Qualitative interviews were conducted with adult daily e-cigarette users.
- Participants were randomized to NRT (patches and lozenges) plus a booklet or Quitline referral.
- Feasibility, acceptability, and 7-day point-prevalence abstinence were assessed.
Main Results:
- Participants cited health concerns, dependence, stigma, and cost as reasons for quitting.
- NRT was feasible and acceptable, with few reported adverse effects.
- 33.3% of participants in the NRT group achieved vaping abstinence versus 0% in the control group (p=.057).
Conclusions:
- Adults are motivated to quit e-cigarettes and are willing to use pharmacotherapy.
- NRT is a potential tool for e-cigarette cessation, warranting further investigation in larger trials.
- Future research should address dual users and disseminate effective treatments.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Antidepressant Drugs: MAOIs and Other Agents